Full-Time

Senior Automation Engineer

Posted on 9/15/2025

Cell Signaling Technology

Cell Signaling Technology

1,001-5,000 employees

Antibody development and validated research tools

No salary listed

Peabody, MA, USA

In Person

Office location: Danvers, MA, USA. No explicit remote option in posting; role appears to be on-site.

Category
Mechanical Engineering (1)
Requirements
  • BS degree (minimum of 8 years of related experience); or Master’s degree (minimum of 6 years experience); or PhD (minimum of 3 years experience). Engineering degree in a relevant field, such as electrical, software or computer science.
  • Minimum of 6 years experience integrating liquid handlers to analytical instrumentation in R&D environment.
  • Proven track record in both writing and optimizing scripts on automated liquid handling platforms leveraging standalone instrument software.
  • Proven track record of creating project plans, track timelines, communicate progress and delays to stakeholders.
  • Demonstrated experience working in a team environment to accomplish company goals and timelines.
  • Flexibility to adapt to business needs, able to work independently and effectively to meet timelines.
  • Excellent written, verbal and customer service skills.
  • Standard Laboratory Work environment.
  • Must be able to remain in a stationary position 50% of the time.
  • May move objects weighing up to 30 pounds across the lab for various needs.
  • Work area can be filled with collaborative discussion.
  • Work area may have noise from equipment (refrigerator, freezer, etc.).
  • Work environment conditions consist of both sitting and standing throughout the day.
Responsibilities
  • Responsible for method development, performance validation training, instrument maintenance, and hardware repair.
  • Collaborate with different cross functional team members and champion automation project planning and execution.
  • Work with scientists to develop, optimize, and implement new automated workflows and systems for the production, characterization and testing of antibody candidates.
  • Perform lab automation development including protocol design, error recovery, point-teaching, liquid class design, order scheduling, run execution leveraging scheduling software (e.g. Cellario, Green Button Go, Sami) and standalone liquid handlers. (e.g. Venus, Biomek, Vwork, Maestro)
  • Monitor and evaluate new and emerging technologies in laboratory automation systems
  • Assist scientists with the operation of automation platforms, providing training and support as needed.
  • Manage equipment scheduling, service contracts and regular equipment preventative maintenance.
Desired Qualifications
  • Experience with Python or equivalent programming language.
  • Knowledge of standard laboratory techniques such as nucleic acid isolation, NGS, protein purification, cell culture and imaging.
  • Experience with assays that enable validation of antibodies.
Cell Signaling Technology

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Cell signaling market grows to $7.11 billion by 2030 at 7.3% CAGR.
  • Bio-Techne adds Simple Western validation to CST antibodies in 2023.
  • CST invests $17.5M in Manchester property in July 2022 for expansion.

What critics are saying

  • Leveragen nanobodies displace CST monoclonal antibodies in 12-24 months.
  • Lunaphore scales single B cell screening, eroding CST revenue in 12-18 months.
  • Visiopharm dependency fails if Indica Labs captures market in 18-36 months.

What makes Cell Signaling Technology unique

  • CST launches SignalStar Multiplex IHC for 8-plex amplification in two days.
  • CST partners with Visiopharm to integrate SignalStar with Phenoplex software.
  • CST expands chimeric monoclonal antibodies to mouse, horse, and feline species.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Tuition Reimbursement

Unlimited Paid Time Off

Parental Leave

Employee Assistance Program

Professional Development Budget

Company News

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.

AZoNetwork
Sep 14th, 2023
Flexible Spatial Biology Solution for Up to 8-Plex Amplification in Two Days: CST Launches SignalStar™ Multiplex IHC

Cell Signaling Technology (CST) , a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC technology, a revolutionary new tool for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays.

INACTIVE